237 related articles for article (PubMed ID: 31174052)
1. A critical review on anti-angiogenic property of phytochemicals.
Rajasekar J; Perumal MK; Vallikannan B
J Nutr Biochem; 2019 Sep; 71():1-15. PubMed ID: 31174052
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis Potential of Phytochemicals for the Therapeutic Management of Tumors.
Munir S; Shah AA; Shahid M; Ahmed MS; Shahid A; Rajoka MSR; Akash MSH; Akram M; Khurshid M
Curr Pharm Des; 2020; 26(2):265-278. PubMed ID: 31886747
[TBL] [Abstract][Full Text] [Related]
3. Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives.
Iqbal J; Abbasi BA; Ahmad R; Batool R; Mahmood T; Ali B; Khalil AT; Kanwal S; Afzal Shah S; Alam MM; Bashir S; Badshah H; Munir A
Biomed Pharmacother; 2019 Jan; 109():1381-1393. PubMed ID: 30551389
[TBL] [Abstract][Full Text] [Related]
4. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
5. Redundant angiogenic signaling and tumor drug resistance.
Gacche RN; Assaraf YG
Drug Resist Updat; 2018 Jan; 36():47-76. PubMed ID: 29499837
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis modulation: the "spice effect".
Bhattacharjee S; Mandal DP
J Environ Pathol Toxicol Oncol; 2012; 31(3):273-83. PubMed ID: 23339701
[TBL] [Abstract][Full Text] [Related]
7. Natural product inhibitors of ocular angiogenesis.
Sulaiman RS; Basavarajappa HD; Corson TW
Exp Eye Res; 2014 Dec; 129():161-71. PubMed ID: 25304218
[TBL] [Abstract][Full Text] [Related]
8. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in anti-angiogenic therapy of cancer.
Samant RS; Shevde LA
Oncotarget; 2011 Mar; 2(3):122-34. PubMed ID: 21399234
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
11. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
[TBL] [Abstract][Full Text] [Related]
12. Anti-vascular endothelial growth factor therapy in breast cancer.
Kristensen TB; Knutsson ML; Wehland M; Laursen BE; Grimm D; Warnke E; Magnusson NE
Int J Mol Sci; 2014 Dec; 15(12):23024-41. PubMed ID: 25514409
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products.
Wahl O; Oswald M; Tretzel L; Herres E; Arend J; Efferth T
Curr Med Chem; 2011; 18(21):3136-55. PubMed ID: 21671856
[TBL] [Abstract][Full Text] [Related]
14. Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?
Islam MS; Akhtar MM; Ciavattini A; Giannubilo SR; Protic O; Janjusevic M; Procopio AD; Segars JH; Castellucci M; Ciarmela P
Mol Nutr Food Res; 2014 Aug; 58(8):1667-84. PubMed ID: 24976593
[TBL] [Abstract][Full Text] [Related]
15. Review of selected patents for cancer therapy targeting tumor angiogenesis.
Kirstein MN; Moore MM; Dudek AZ
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
[TBL] [Abstract][Full Text] [Related]
16. Plants and their active compounds: natural molecules to target angiogenesis.
Lu K; Bhat M; Basu S
Angiogenesis; 2016 Jul; 19(3):287-95. PubMed ID: 27154020
[TBL] [Abstract][Full Text] [Related]
17. The angiogenic process as a therapeutic target in cancer.
Bridges EM; Harris AL
Biochem Pharmacol; 2011 May; 81(10):1183-91. PubMed ID: 21382350
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer.
Bertolini F; Marighetti P; Martin-Padura I; Mancuso P; Hu-Lowe DD; Shaked Y; D'Onofrio A
Drug Discov Today; 2011 Dec; 16(23-24):1052-60. PubMed ID: 21875682
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic therapy in pediatric brain tumors: an effective strategy?
Sie M; den Dunnen WF; Hoving EW; de Bont ES
Crit Rev Oncol Hematol; 2014 Mar; 89(3):418-32. PubMed ID: 24169416
[TBL] [Abstract][Full Text] [Related]
20. Development of new drugs in angiogenesis.
Ziche M; Donnini S; Morbidelli L
Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
